Michael Harsh
CIK 1706155 · last filed 2026-01-23
Michael Harsh is a corporate insider who has filed 20 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for NDRA, was dated Jan 23, 2026. Across all open-market trades the lifetime net is +$11.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $299.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$299.6K
2
20
$11.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NDRA | Director | 65,710 | $4.56 | $299.6K | $0 | 4 | 2026-01-23 |
| ENDRA Life Sciences Inc. (NDRAW) Delisted | Director | 69,243 | $0.03 | $2.1K | $11.2K | 15 | 2022-03-30 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-23 | NDRA | Grant (A) | +60,324 | $0 | EDGAR |
| 2025-07-01 | NDRA | Grant (A) | +5,384 | $0 | EDGAR |
| 2024-02-23 | NDRA | Grant (A) | — | $0 | EDGAR |
| 2023-08-03 | — | Mixed | −10,000 | $0 | |
| 2023-02-01 | NDRA | Grant (A) | — | $0 | EDGAR |
| 2022-03-30 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-04 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-07 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-25 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-24 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Exer (X) | +5,000 | $4.3K | EDGAR |